{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:42:05Z","timestamp":1792791725636,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010840","name":"Guangdong Provincial Academy of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013050","name":"Guangdong Provincial Applied Science and Technology Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011492","name":"Jiangmen Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Provincial Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.cellsig.2025.111676","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T09:20:52Z","timestamp":1740475252000},"page":"111676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["m6A-mediated regulation of CPSF6 by METTL3 promotes oxaliplatin resistance in colorectal cancer through enhanced glycolysis"],"prefix":"10.1016","volume":"130","author":[{"given":"Chengxing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jietao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaorong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2025.111676_bb0005","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cellsig.2025.111676_bb0010","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","article-title":"Colorectal cancer","volume":"383","author":"Brenner","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.cellsig.2025.111676_bb0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","article-title":"Metastatic colorectal cancer: mechanisms and emerging therapeutics","volume":"44","author":"Shin","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cellsig.2025.111676_bb0020","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","article-title":"Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial","volume":"27","author":"Andr\u00e9","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2025.111676_bb0025","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1200\/JCO.22.02759","article-title":"A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer","volume":"41","author":"Goldberg","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2025.111676_bb0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13046-021-01884-z","article-title":"CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression","volume":"40","author":"Tan","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111676_bb0035","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.2147\/CMAR.S239664","article-title":"NUDT21 suppresses breast cancer tumorigenesis through regulating CPSF6 expression","volume":"12","author":"Wang","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.cellsig.2025.111676_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113197","article-title":"CPSF6 regulates alternative polyadenylation and proliferation of cancer cells through phase separation","volume":"42","author":"Liu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellsig.2025.111676_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100933","article-title":"CPSF6-mediated XBP1 3\u2032UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma","volume":"68","author":"Zhu","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.cellsig.2025.111676_bb0050","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1158\/0008-5472.CAN-22-0909","article-title":"An alternatively spliced p62 isoform confers resistance to chemotherapy in breast cancer","volume":"82","author":"Guo","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111676_bb0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13046-021-01934-6","article-title":"Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt\/\u03b2-catenin pathway","volume":"40","author":"Liu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111676_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103362","article-title":"LncRNA-HMG incites colorectal cancer cells to chemoresistance via repressing p53-mediated ferroptosis","volume":"77","author":"Xin","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.cellsig.2025.111676_bb0065","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","article-title":"Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer","volume":"20","author":"Li","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.cellsig.2025.111676_bb0070","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2147\/OTT.S284211","article-title":"CPNE1 enhances colorectal cancer cell growth, glycolysis, and drug resistance through regulating the AKT-GLUT1\/HK2 pathway","volume":"14","author":"Wang","year":"2021","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.cellsig.2025.111676_bb0075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1476-4598-12-152","article-title":"Tumor glycolysis as a target for cancer therapy: progress and prospects","volume":"12","author":"Ganapathy-Kanniappan","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2025.111676_bb0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41423-021-00727-3","article-title":"The therapeutic implications of immunosuppressive tumor aerobic glycolysis","volume":"19","author":"Reinfeld","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cellsig.2025.111676_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","article-title":"How the Warburg effect supports aggressiveness and drug resistance of cancer cells?","volume":"38","author":"Icard","year":"2018","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.cellsig.2025.111676_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710037","article-title":"Revisited metabolic control and reprogramming cancers by means of the Warburg effect in tumor cells","volume":"23","author":"Fukushi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2025.111676_bb0095","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1113\/JP278810","article-title":"Revisiting the Warburg effect: historical dogma versus current understanding","volume":"599","author":"Vaupel","year":"2021","journal-title":"J. Physiol."},{"key":"10.1016\/j.cellsig.2025.111676_bb0100","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s43440-023-00504-1","article-title":"The Warburg effect: a score for many instruments in the concert of cancer and cancer niche cells","volume":"75","author":"Jaworska","year":"2023","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.cellsig.2025.111676_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbabio.2022.148931","article-title":"The Warburg effect and mitochondrial oxidative phosphorylation: friends or foes?","volume":"1864","author":"Martins Pinto","year":"2023","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.cellsig.2025.111676_bb0110","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1172\/JCI127201","article-title":"Adipocyte and lipid metabolism in cancer drug resistance","volume":"129","author":"Cao","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2025.111676_bb0115","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.canlet.2019.03.024","article-title":"UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer","volume":"452","author":"Hu","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2025.111676_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2021.07.016","article-title":"Knockdown of NOVA1 inhibits inflammation and migration of asthmatic airway smooth muscle cells to regulate PTEN\/Akt pathway by targeting PTBP1","volume":"138","author":"Cheng","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellsig.2025.111676_bb0125","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1002\/jcp.26406","article-title":"Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis","volume":"233","author":"Hsu","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cellsig.2025.111676_bb0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12938-021-00903-6","article-title":"Ribonucleic acid-binding protein CPSF6 promotes glycolysis and suppresses apoptosis in hepatocellular carcinoma cells by inhibiting the BTG2 expression","volume":"20","author":"Liu","year":"2021","journal-title":"Biomed. Eng. Online"},{"key":"10.1016\/j.cellsig.2025.111676_bb0135","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.7150\/ijbs.93462","article-title":"Negative regulation of CPSF6 suppresses the Warburg effect and angiogenesis leading to tumor progression via c-Myc signaling network: potential therapeutic target for liver cancer therapy","volume":"20","author":"Sim","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cellsig.2025.111676_bb0140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-019-0981-7","article-title":"Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer","volume":"18","author":"Liu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2025.111676_bb0145","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","article-title":"Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression","volume":"73","author":"Li","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cellsig.2025.111676_bb0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00432-013-1545-7","article-title":"FDG PET\/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma","volume":"140","author":"Chung","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2025.111676_bb0155","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.2967\/jnumed.108.054098","article-title":"18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization","volume":"50","author":"Jadvar","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.cellsig.2025.111676_bb0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cellsig.2025.111676_bb0165","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","article-title":"Colorectal cancer in inflammatory bowel disease: mechanisms and management","volume":"162","author":"Shah","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cellsig.2025.111676_bb0170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13073-019-0703-1","article-title":"Molecular profiling for precision cancer therapies","volume":"12","author":"Malone","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.cellsig.2025.111676_bb0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","article-title":"Notch signaling pathway: architecture, disease, and therapeutics","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cellsig.2025.111676_bb0180","doi-asserted-by":"crossref","first-page":"9300","DOI":"10.18632\/aging.204407","article-title":"The roles of CPSF6 in proliferation, apoptosis and tumorigenicity of lung adenocarcinoma","volume":"14","author":"Zu","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cellsig.2025.111676_bb0185","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1182\/bloodadvances.2022008364","article-title":"A global study for acute myeloid leukemia with RARG rearrangement","volume":"7","author":"Zhu","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.cellsig.2025.111676_bb0190","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.4251\/wjgo.v15.i9.1531","article-title":"RNA-binding protein CPSF6 regulates IBSP to affect pyroptosis in gastric cancer","volume":"15","author":"Wang","year":"2023","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.cellsig.2025.111676_bb0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ebiom.2017.06.023","article-title":"CPSF6 is a clinically relevant breast cancer vulnerability target: role of CPSF6 in breast cancer","volume":"21","author":"Binothman","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cellsig.2025.111676_bb0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.21147\/j.issn.1000-9604.2022.01.02","article-title":"Deregulated expression and subcellular localization of CPSF6, a circRNA-binding protein, promote malignant development of esophageal squamous cell carcinoma","volume":"34","author":"Guo","year":"2022","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111676_bb0205","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41423-021-00806-5","article-title":"The transcription factor KLF14 regulates macrophage glycolysis and immune function by inhibiting HK2 in sepsis","volume":"19","author":"Yuan","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cellsig.2025.111676_bb0210","article-title":"Targeting YAP1-regulated glycolysis in fibroblast-like synoviocytes impairs macrophage infiltration to ameliorate diabetic osteoarthritis progression","volume":"11","author":"Yang","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.cellsig.2025.111676_bb0215","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13045-022-01348-7","article-title":"Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p\/BPTF axis and degrading BIN1","volume":"15","author":"Lin","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2025.111676_bb0220","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41419-024-06446-7","article-title":"USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2025.111676_bb0225","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13046-020-01808-3","article-title":"Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b\/\u03b2-catenin\/c-Myc signaling and reprogramming glycolysis","volume":"40","author":"Jiang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111676_bb0230","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ccell.2016.10.006","article-title":"Inhibition of the glycolytic activator PFKFB3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapy","volume":"30","author":"Cantelmo","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2025.111676_bb0235","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13046-015-0221-y","article-title":"Metabolic reprogramming: the emerging concept and associated therapeutic strategies","volume":"34","author":"Yoshida","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111676_bb0240","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","article-title":"Macrophages and metabolism in the tumor microenvironment","volume":"30","author":"Vitale","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.cellsig.2025.111676_bb0245","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41419-022-04632-z","article-title":"Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer","volume":"13","author":"Jiang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2025.111676_bb0250","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2025.111676_bb0255","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1152\/physrev.00001.2017","article-title":"Endothelial cell metabolism","volume":"98","author":"Eelen","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cellsig.2025.111676_bb0260","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1080\/15548627.2023.2246356","article-title":"Lactate is a bridge linking glycolysis and autophagy through lactylation","volume":"19","author":"Sun","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.cellsig.2025.111676_bb0265","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/15548627.2015.1042195","article-title":"HK2\/hexokinase-II integrates glycolysis and autophagy to confer cellular protection","volume":"11","author":"Tan","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.cellsig.2025.111676_bb0270","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semcancer.2024.03.001","article-title":"GLUT and HK: two primary and essential key players in tumor glycolysis","volume":"100","author":"Yadav","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.cellsig.2025.111676_bb0275","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-019-0805-7","article-title":"The interplay between m6A RNA methylation and noncoding RNA in cancer","volume":"12","author":"Ma","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2025.111676_bb0280","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molcel.2023.01.006","article-title":"RNA m6A methylation across the transcriptome","volume":"83","author":"Sendinc","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellsig.2025.111676_bb0285","article-title":"Targeting key RNA methylation enzymes to improve the outcome of colorectal cancer chemotherapy (review)","volume":"64","author":"Shao","year":"2024","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cellsig.2025.111676_bb0290","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/gutjnl-2022-328845","article-title":"Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer","volume":"72","author":"Bao","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.cellsig.2025.111676_bb0295","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.7150\/thno.73746","article-title":"N(6)-methyladenosine-mediated LDHA induction potentiates chemoresistance of colorectal cancer cells through metabolic reprogramming","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.cellsig.2025.111676_bb0300","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13045-020-00951-w","article-title":"Roles of METTL3 in cancer: mechanisms and therapeutic targeting","volume":"13","author":"Zeng","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2025.111676_bb0305","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cellsig.2025.111676_bb0310","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.cell.2020.05.012","article-title":"A unified model for the function of YTHDF proteins in regulating m(6)A-modified mRNA","volume":"181","author":"Zaccara","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2025.111676_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101063","article-title":"Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer","volume":"73","author":"Ou","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.cellsig.2025.111676_bb0320","article-title":"YTHDF1 promotes bladder cancer cell proliferation via the METTL3\/YTHDF1-RPN2-PI3K\/AKT\/mTOR Axis","volume":"24","author":"Zhu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2025.111676_bb0325","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2025.111676_bb0330","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","article-title":"Targeting FTO suppresses cancer stem cell maintenance and immune evasion","volume":"38","author":"Su","year":"2020","journal-title":"Cancer Cell"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825000890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825000890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T03:24:42Z","timestamp":1741663482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825000890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":66,"alternative-id":["S0898656825000890"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111676","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"m6A-mediated regulation of CPSF6 by METTL3 promotes oxaliplatin resistance in colorectal cancer through enhanced glycolysis","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111676"}}